Display options
Share it on

Open Heart. 2017 May 22;4(1):e000569. doi: 10.1136/openhrt-2016-000569. eCollection 2017.

Long-term left ventricular remodelling after revascularisation for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging.

Open heart

Mariella Ecj Hassell, Wieneke Vlastra, Lourens Robbers, Alexander Hirsch, Robin Nijveldt, Jan Gp Tijssen, Albert C van Rossum, Felix Zijlstra, Jan J Piek, Ronak Delewi

Affiliations

  1. Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  2. Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands.
  3. Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands.
  4. Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands.

PMID: 28861274 PMCID: PMC5577529 DOI: 10.1136/openhrt-2016-000569

Abstract

OBJECTIVE: Left ventricular remodelling following a ST-segment elevated myocardial infarction (STEMI) is an adaptive response to maintain the cardiac output despite myocardial tissue loss. Limited studies have evaluated long term ventricular function using cardiac magnetic resonance imaging (CMR) after STEMI.

METHODS: Study population consisted of 155 primary percutaneous coronary intervention treated first STEMI patients. CMR was performed at 4±2 days, 4 months and 24 months follow-up. Patients were treated with beta-blockers, ACE-inhibitors or AT-II- inhibitors, statins and dual antiplatelet according to current international guidelines.

RESULTS: Mean left ventricular ejection fraction (LVEF) at baseline was 44%±8%. Twenty-one per cent of the study population had an increase of more than 5.0% after 4 months of follow-up and 21% of the cohort had a decrease of more than 5.0%. Patients with long-term LVEF deterioration have significantly larger end-systolic volumes than patients with improvement of LVEF (61±23 mL/m

CONCLUSION: Contrary to previous studies, we demonstrate that myocardial remodelling after STEMI is a long-term process. Long-term LVEF deterioration is characterised by an increase in end-systolic volume and less wall thickening in the remote zones. Patients with LVEF improvement exhibit an increase in left ventricular wall thickening both in the infarct as well as in the remote zones.

TRIAL REGISTRATION: The HEBE study is registered in The Netherlands Trial Register #NTR166 (www.trialregister.nl) and the International Standard Randomised Controlled Trial, #ISRCTN95796863 (https://c-d-qn9pqajji.sec.amc.nl).

Keywords: MRI; STEMI; cardiac remodelling

Conflict of interest statement

Competing interests: None declared.

References

  1. Ann Intern Med. 2001 Mar 20;134(6):451-8 - PubMed
  2. Circulation. 2002 Aug 27;106(9):1083-9 - PubMed
  3. Circulation. 1992 Aug;86(2):431-8 - PubMed
  4. N Engl J Med. 1988 Jul 14;319(2):80-6 - PubMed
  5. J Mol Cell Cardiol. 1993 Feb;25(2):133-43 - PubMed
  6. Lancet. 1988 Feb 6;1(8580):255-9 - PubMed
  7. Eur Heart J. 2011 Jul;32(14):1736-47 - PubMed
  8. Circulation. 1987 Jul;76(1):44-51 - PubMed
  9. J Am Coll Cardiol. 2000 Mar 1;35(3):569-82 - PubMed
  10. J Am Coll Cardiol. 1992 May;19(6):1136-44 - PubMed
  11. Int J Cardiovasc Imaging. 2013 Apr;29(4):787-95 - PubMed
  12. Circulation. 1993 Nov;88(5 Pt 1):2277-83 - PubMed
  13. Lancet. 2006 Jan 28;367(9507):356-67 - PubMed
  14. Circ Cardiovasc Imaging. 2009 Jan;2(1):47-55 - PubMed
  15. JACC Cardiovasc Imaging. 2008 Sep;1(5):582-91 - PubMed
  16. Circulation. 1999 Jan 5-12;99(1):36-43 - PubMed
  17. J Am Coll Cardiol. 2008 Jul 15;52(3):181-9 - PubMed
  18. Circulation. 2004 Mar 9;109(9):1161-7 - PubMed
  19. Circulation. 2001 Sep 4;104(10):1101-7 - PubMed
  20. Am J Cardiol. 1993 Sep 15;72 (9):672-6 - PubMed
  21. Circulation. 1997 Nov 18;96(10):3294-9 - PubMed
  22. J Am Coll Cardiol. 2000 May;35(6):1525-34 - PubMed
  23. Int J Cardiovasc Imaging. 2013 Apr;29(4):835-42 - PubMed
  24. Circulation. 1997 Dec 2;96(11):4065-82 - PubMed
  25. J Am Coll Cardiol. 2003 Sep 3;42(5):895-901 - PubMed
  26. J Am Coll Cardiol. 1993 Mar 1;21(3):673-82 - PubMed
  27. J Biol Chem. 1992 May 25;267(15):10551-60 - PubMed
  28. J Physiol. 2003 Feb 1;546(Pt 3):777-87 - PubMed
  29. Lancet. 1991 Apr 13;337(8746):872-6 - PubMed
  30. J Am Coll Cardiol. 1997 Apr;29(5):1060-6 - PubMed
  31. Am J Cardiol. 2006 Nov 1;98(9):1144-9 - PubMed
  32. J Am Coll Cardiol. 2005 Mar 15;45(6):901-9 - PubMed
  33. Circulation. 1997 Jul 1;96(1):183-91 - PubMed
  34. Circ J. 2013;77(1):81-8 - PubMed
  35. Circulation. 1996 Aug 15;94(4):660-6 - PubMed
  36. J Am Coll Cardiol. 2006 Mar 7;47(5):969-77 - PubMed
  37. Cardiology. 2001;96(2):106-14 - PubMed
  38. J Cardiovasc Magn Reson. 2012 Sep 02;14:62 - PubMed
  39. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):43A-48A - PubMed
  40. N Engl J Med. 1979 Jan 11;300(2):57-62 - PubMed
  41. JACC Cardiovasc Imaging. 2011 Jan;4(1):98-108 - PubMed
  42. Am J Cardiol. 1982 Apr 1;49(5):1120-6 - PubMed
  43. Circulation. 1990 Apr;81(4):1161-72 - PubMed
  44. Circulation. 1995 May 15;91(10 ):2573-81 - PubMed
  45. N Engl J Med. 1998 Jul 16;339(3):173-81 - PubMed
  46. Circulation. 1986 Oct;74(4):693-702 - PubMed

Publication Types